These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 23359508)
1. Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets. Mamessier E; Pradel LC; Thibult ML; Drevet C; Zouine A; Jacquemier J; Houvenaeghel G; Bertucci F; Birnbaum D; Olive D J Immunol; 2013 Mar; 190(5):2424-36. PubMed ID: 23359508 [TBL] [Abstract][Full Text] [Related]
2. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Gaddy J; Broxmeyer HE Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743 [TBL] [Abstract][Full Text] [Related]
3. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534 [TBL] [Abstract][Full Text] [Related]
4. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells. Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217 [TBL] [Abstract][Full Text] [Related]
5. Role of chemokines in the biology of natural killer cells. Maghazachi AA Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317 [TBL] [Abstract][Full Text] [Related]
6. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499 [TBL] [Abstract][Full Text] [Related]
7. Differential oncolytic effect of NK-enriched subsets in long-term interleukin-2 cultures. Fuchshuber PR; Lotzová E Lymphokine Cytokine Res; 1992 Oct; 11(5):271-6. PubMed ID: 1281676 [TBL] [Abstract][Full Text] [Related]
8. Natural killer cell subsets and their functional molecules in peripheral blood of the patients with breast cancer. Darvishvand R; Rezaeifard S; Kiani R; Tahmasebi S; Faghih Z; Erfani N Immun Inflamm Dis; 2024 Apr; 12(4):e1255. PubMed ID: 38652012 [TBL] [Abstract][Full Text] [Related]
9. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional heterogeneity of natural killer cells from umbilical cord blood mononuclear cells. Fan YY; Yang BY; Wu CY Immunol Invest; 2008; 37(1):79-96. PubMed ID: 18214801 [TBL] [Abstract][Full Text] [Related]
12. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation. Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005 [TBL] [Abstract][Full Text] [Related]
13. Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs. Fan YY; Yang BY; Wu CY Cell Biol Int; 2008 Feb; 32(2):188-97. PubMed ID: 17920947 [TBL] [Abstract][Full Text] [Related]
14. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125). Belisle JA; Gubbels JA; Raphael CA; Migneault M; Rancourt C; Connor JP; Patankar MS Immunology; 2007 Nov; 122(3):418-29. PubMed ID: 17617155 [TBL] [Abstract][Full Text] [Related]
15. IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion. Huenecke S; Zimmermann SY; Kloess S; Esser R; Brinkmann A; Tramsen L; Koenig M; Erben S; Seidl C; Tonn T; Eggert A; Schramm A; Bader P; Klingebiel T; Lehrnbecher T; Passweg JR; Soerensen J; Schwabe D; Koehl U J Immunother; 2010; 33(2):200-10. PubMed ID: 20145545 [TBL] [Abstract][Full Text] [Related]
16. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. Hanna J; Bechtel P; Zhai Y; Youssef F; McLachlan K; Mandelboim O J Immunol; 2004 Dec; 173(11):6547-63. PubMed ID: 15557145 [TBL] [Abstract][Full Text] [Related]
17. Analysis of CD16+dim and CD16+bright lymphocytes--comparison of peripheral and clonal non-MHC-restricted T cells and NK cells. Uciechowski P; Werfel T; Leo R; Gessner JE; Schubert J; Schmidt RE Immunobiology; 1992 Jun; 185(1):28-40. PubMed ID: 1398740 [TBL] [Abstract][Full Text] [Related]
18. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer. Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357 [TBL] [Abstract][Full Text] [Related]
19. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training. Suzui M; Kawai T; Kimura H; Takeda K; Yagita H; Okumura K; Shek PN; Shephard RJ J Appl Physiol (1985); 2004 Jun; 96(6):2167-73. PubMed ID: 14752119 [TBL] [Abstract][Full Text] [Related]
20. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy. Antonaci S; Polignano A; Ottolenghi A; Tortorella C; Schena FP Cytobios; 1992; 69(276):27-34. PubMed ID: 1374697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]